使用SV40大T抗原的有条件不朽化及其对诱导多能干细胞向视网膜原生细胞分化的影响
Qi Wang1, Brittany N Allen1, Laura R Bohrer2,3
1Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, USA.
Stem cells and development
|November 29, 2024
概括
从人类诱导的多能干细胞 (iPSCs) 来制造不朽的视网膜原生细胞 (RPCs) 用于疾病研究,这是一项具有挑战性的工作. 虽然不朽化促进了增殖,但它不可逆转地损害了RPC分化潜力,阻碍了治疗的发展.
科学领域:
- 生物医学工程 生物医学工程
- 干细胞生物学 干细胞生物学
- 眼科医生 眼科 眼科
背景情况:
- 视网膜退行性疾病缺乏有效的治疗方法,使用视网膜原生细胞 (RPC) 的细胞替代疗法显示出有前途.
- 开发这些疗法需要大量的RPC,但它们从人类诱导的多能干细胞 (iPSC) 进行大规模生产是资源密集的.
- 目前用于产生足够的RPC用于研究和治疗开发的方法有限.
研究的目的:
- 从iPSCs创建一个有条件的永生的人类RPC细胞系,以克服生产障碍.
- 调查SV40大T (SV40-T) 抗原介导不朽化对RPC增殖和分化的影响.
- 评估使用Tet-On SV40-T永久化RPCs用于视网膜治疗的体外试验的可行性.
主要方法:
- 人类iPSCs用Tet-On SV40-T系统进行了转换,用于有条件的永生.
- 分析了RPC增殖和分化标志物 (PAX6,SOX2,CHX10) 在使用和不使用多西环素时的情况.
- 评估了多西环林去除后差异化变化的可逆性.
主要成果:
- SV40-T抗原表达显著增加了RPC扩散.
- 不朽化导致RPC身份和多功能的大量丧失,主要标记物的表达减少表明了这一点.
- 观察到的脱差是不可逆转的,即使在多西环林戒药后.
结论:
- 使用Tet-On SV40-T抗原进行有条件的不朽化,在保持RPC身份和差异化潜力方面存在挑战.
- 为了开发可靠的RPC用于研究和治疗,平衡增强的增殖与保留的分化能力至关重要.
- 为了推进基于干细胞的视网膜疾病治疗,需要进一步优化永生化技术和培养条件.
更多相关视频
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K